[Form 4] RadNet, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider sale recorded: Cornelis Wesdorp, listed as President & CEO, Digital Health and a director of RadNet, Inc. (RDNT), reported selling 1,500 shares of common stock on 08/19/2025 at a price of $66.98 per share. After the sale he beneficially owned 54,495 shares in a direct form. The Form 4 was signed by an attorney-in-fact on 08/21/2025.

Insights

Securities Analyst

TL;DR: Routine insider sale disclosed; size and context not provided to indicate material impact.

The sale of 1,500 shares at $66.98 reduces the reporting person's direct holdings to 54,495 shares. The filing presents no additional context such as a trading plan, tax-related sale, or change in role. As reported, this is a standard Section 16 disclosure of a transaction by an officer/director and does not by itself indicate a material change to company ownership or control.

Corporate Governance Expert

TL;DR: Disclosure meets Section 16 requirements; no governance issues or related-party transactions are disclosed.

The Form 4 identifies the reporting person as an officer and director and records a direct disposition. The form is properly signed by an attorney-in-fact. There are no indications of related-party transfers, derivative transactions, or amendments. From a governance perspective, the filing is routine recordkeeping and transparency of insider activity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wesdorp Cornelis

(Last) (First) (Middle)

C/O RADNET, INC.

1510 COTNER AVENUE

(Street)

LOS ANGELES CA 90025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RadNet, Inc. [ RDNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres & CEO, Digital Health

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		S		1,500	D	$66.98	54,495	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jose Gamez, Attorney-in-Fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did RadNet (RDNT) disclose in this Form 4?

The filing reports that Cornelis Wesdorp sold 1,500 shares of RadNet common stock on 08/19/2025 at $66.98 per share.

How many RadNet shares does the reporting person own after the sale?

After the reported transaction, the reporting person directly beneficially owned 54,495 shares.

What is the reporting person's role at RadNet (RDNT)?

The Form 4 lists Cornelis Wesdorp as a Director and an Officer with the title Pres & CEO, Digital Health.

When was the Form 4 signed and by whom?

The form was signed by Jose Gamez, Attorney-in-Fact on 08/21/2025.

Does the Form 4 show any derivative transactions or option exercises?

No. Table II (derivative securities) contains no reported transactions or holdings in this filing.